APOLLO GLOBAL MANAGEMENT INC (APO) Fundamental Analysis & Valuation

NYSE:APO • US03769M1062

Current stock price

122.28 USD
-1.29 (-1.04%)
At close:
122.01 USD
-0.27 (-0.22%)
After Hours:

This APO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. APO Profitability Analysis

1.1 Basic Checks

  • APO had positive earnings in the past year.
  • APO had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: APO reported negative net income in multiple years.
  • Each year in the past 5 years APO had a positive operating cash flow.
APO Yearly Net Income VS EBIT VS OCF VS FCFAPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B

1.2 Ratios

  • The Return On Assets of APO (0.71%) is worse than 61.00% of its industry peers.
  • APO has a better Return On Equity (14.08%) than 70.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.47%, APO is in line with its industry, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.71%
ROE 14.08%
ROIC 1.47%
ROA(3y)0.64%
ROA(5y)1.66%
ROE(3y)9.76%
ROE(5y)17.05%
ROIC(3y)N/A
ROIC(5y)N/A
APO Yearly ROA, ROE, ROICAPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • The Profit Margin of APO (11.44%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of APO has declined.
  • With a decent Operating Margin value of 26.51%, APO is doing good in the industry, outperforming 74.00% of the companies in the same industry.
  • APO's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 26.51%
PM (TTM) 11.44%
GM N/A
OM growth 3Y-2.59%
OM growth 5Y-7.21%
PM growth 3Y-15.29%
PM growth 5Y-7.97%
GM growth 3YN/A
GM growth 5YN/A
APO Yearly Profit, Operating, Gross MarginsAPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. APO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), APO is destroying value.
  • APO has more shares outstanding than it did 1 year ago.
  • APO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, APO has an improved debt to assets ratio.
APO Yearly Shares OutstandingAPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
APO Yearly Total Debt VS Total AssetsAPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B

2.2 Solvency

  • APO has an Altman-Z score of 0.20. This is a bad value and indicates that APO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.20, APO perfoms like the industry average, outperforming 47.00% of the companies in the same industry.
  • APO has a debt to FCF ratio of 4.11. This is a neutral value as APO would need 4.11 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.11, APO is doing good in the industry, outperforming 69.00% of the companies in the same industry.
  • APO has a Debt/Equity ratio of 0.57. This is a neutral value indicating APO is somewhat dependend on debt financing.
  • The Debt to Equity ratio of APO (0.57) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.11
Altman-Z 0.2
ROIC/WACC0.17
WACC8.49%
APO Yearly LT Debt VS Equity VS FCFAPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

2.3 Liquidity

  • APO has a Current Ratio of 0.04. This is a bad value and indicates that APO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • APO has a worse Current ratio (0.04) than 82.00% of its industry peers.
  • APO has a Quick Ratio of 0.04. This is a bad value and indicates that APO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.04, APO is not doing good in the industry: 82.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
APO Yearly Current Assets VS Current LiabilitesAPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. APO Growth Analysis

3.1 Past

  • APO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.79%, which is quite good.
  • APO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.92% yearly.
  • The Revenue has grown by 21.01% in the past year. This is a very strong growth!
EPS 1Y (TTM)12.79%
EPS 3Y19.02%
EPS 5Y32.92%
EPS Q2Q%11.26%
Revenue 1Y (TTM)21.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%86.71%

3.2 Future

  • Based on estimates for the next years, APO will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.68% on average per year.
  • The Revenue is expected to decrease by -15.93% on average over the next years. This is quite bad
EPS Next Y10.94%
EPS Next 2Y14.4%
EPS Next 3Y15.24%
EPS Next 5Y12.68%
Revenue Next Year38.08%
Revenue Next 2Y25%
Revenue Next 3Y20.7%
Revenue Next 5Y-15.93%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
APO Yearly Revenue VS EstimatesAPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
APO Yearly EPS VS EstimatesAPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. APO Valuation Analysis

4.1 Price/Earnings Ratio

  • APO is valuated correctly with a Price/Earnings ratio of 14.59.
  • The rest of the industry has a similar Price/Earnings ratio as APO.
  • APO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.54.
  • Based on the Price/Forward Earnings ratio of 13.15, the valuation of APO can be described as correct.
  • APO's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, APO is valued a bit cheaper.
Industry RankSector Rank
PE 14.59
Fwd PE 13.15
APO Price Earnings VS Forward Price EarningsAPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, APO is valued a bit cheaper than 78.00% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as APO.
Industry RankSector Rank
P/FCF 21.74
EV/EBITDA 7.65
APO Per share dataAPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • APO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • APO's earnings are expected to grow with 15.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.33
PEG (5Y)0.44
EPS Next 2Y14.4%
EPS Next 3Y15.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. APO Dividend Analysis

5.1 Amount

  • APO has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.81, APO pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, APO has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of APO decreases each year by -2.66%.
  • APO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • APO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-2.66%
Div Incr Years3
Div Non Decr Years3
APO Yearly Dividends per shareAPO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 36.17% of the earnings are spent on dividend by APO. This is a low number and sustainable payout ratio.
DP36.17%
EPS Next 2Y14.4%
EPS Next 3Y15.24%
APO Yearly Income VS Free CF VS DividendAPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B
APO Dividend Payout.APO Dividend Payout, showing the Payout Ratio.APO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

APO Fundamentals: All Metrics, Ratios and Statistics

APOLLO GLOBAL MANAGEMENT INC

NYSE:APO (4/29/2026, 7:00:00 PM)

After market: 122.01 -0.27 (-0.22%)

122.28

-1.29 (-1.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Industry Strength40.99
Industry Growth55.28
Earnings (Last)02-09
Earnings (Next)05-06
Inst Owners67.48%
Inst Owner Change-92.21%
Ins Owners2.58%
Ins Owner Change-2.25%
Market Cap70.71B
Revenue(TTM)28.72B
Net Income(TTM)3.29B
Analysts80
Price Target150.74 (23.27%)
Short Float %7.34%
Short Ratio5.33
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.27
Dividend Growth(5Y)-2.66%
DP36.17%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-19
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.84%
Min EPS beat(2)12.41%
Max EPS beat(2)19.26%
EPS beat(4)3
Avg EPS beat(4)7.84%
Min EPS beat(4)-3.45%
Max EPS beat(4)19.26%
EPS beat(8)5
Avg EPS beat(8)5.25%
EPS beat(12)7
Avg EPS beat(12)3.78%
EPS beat(16)9
Avg EPS beat(16)3.77%
Revenue beat(2)2
Avg Revenue beat(2)87.73%
Min Revenue beat(2)81.79%
Max Revenue beat(2)93.67%
Revenue beat(4)4
Avg Revenue beat(4)61.08%
Min Revenue beat(4)22.26%
Max Revenue beat(4)93.67%
Revenue beat(8)8
Avg Revenue beat(8)60.75%
Revenue beat(12)11
Avg Revenue beat(12)86.52%
Revenue beat(16)14
Avg Revenue beat(16)94.38%
PT rev (1m)-7.76%
PT rev (3m)-10.78%
EPS NQ rev (1m)-7.39%
EPS NQ rev (3m)-7.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.1%
Revenue NQ rev (1m)-4.43%
Revenue NQ rev (3m)-4.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 14.59
Fwd PE 13.15
P/S 2.46
P/FCF 21.74
P/OCF 21.74
P/B 3.03
P/tB 4.06
EV/EBITDA 7.65
EPS(TTM)8.38
EY6.85%
EPS(NY)9.3
Fwd EY7.6%
FCF(TTM)5.63
FCFY4.6%
OCF(TTM)5.63
OCFY4.6%
SpS49.67
BVpS40.36
TBVpS30.13
PEG (NY)1.33
PEG (5Y)0.44
Graham Number87.2399 (-28.66%)
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 14.08%
ROCE 1.71%
ROIC 1.47%
ROICexc 1.53%
ROICexgc 1.83%
OM 26.51%
PM (TTM) 11.44%
GM N/A
FCFM 11.33%
ROA(3y)0.64%
ROA(5y)1.66%
ROE(3y)9.76%
ROE(5y)17.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-33.79%
ROICexgc growth 5Y-38.36%
ROICexc growth 3Y-35.62%
ROICexc growth 5Y-38.99%
OM growth 3Y-2.59%
OM growth 5Y-7.21%
PM growth 3Y-15.29%
PM growth 5Y-7.97%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.11
Debt/EBITDA 1.54
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 9.46
Cash Conversion 37.44%
Profit Quality 98.97%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 0.2
F-Score4
WACC8.49%
ROIC/WACC0.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.79%
EPS 3Y19.02%
EPS 5Y32.92%
EPS Q2Q%11.26%
EPS Next Y10.94%
EPS Next 2Y14.4%
EPS Next 3Y15.24%
EPS Next 5Y12.68%
Revenue 1Y (TTM)21.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%86.71%
Revenue Next Year38.08%
Revenue Next 2Y25%
Revenue Next 3Y20.7%
Revenue Next 5Y-15.93%
EBIT growth 1Y2.64%
EBIT growth 3Y54.01%
EBIT growth 5Y41.09%
EBIT Next Year16.61%
EBIT Next 3Y16.04%
EBIT Next 5Y14.11%
FCF growth 1Y-48.54%
FCF growth 3Y48.2%
FCF growth 5Y25.54%
OCF growth 1Y-48.54%
OCF growth 3Y45.14%
OCF growth 5Y24.61%

APOLLO GLOBAL MANAGEMENT INC / APO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for APOLLO GLOBAL MANAGEMENT INC?

ChartMill assigns a fundamental rating of 3 / 10 to APO.


Can you provide the valuation status for APOLLO GLOBAL MANAGEMENT INC?

ChartMill assigns a valuation rating of 4 / 10 to APOLLO GLOBAL MANAGEMENT INC (APO). This can be considered as Fairly Valued.


How profitable is APOLLO GLOBAL MANAGEMENT INC (APO) stock?

APOLLO GLOBAL MANAGEMENT INC (APO) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for APO stock?

The Price/Earnings (PE) ratio for APOLLO GLOBAL MANAGEMENT INC (APO) is 14.59 and the Price/Book (PB) ratio is 3.03.


How financially healthy is APOLLO GLOBAL MANAGEMENT INC?

The financial health rating of APOLLO GLOBAL MANAGEMENT INC (APO) is 2 / 10.